Role of microRNAs in Chronic Lymphocytic Leukemia Pathogenesis

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression in cellular processes like growth and differentiation.
• Aberrations in the 13q14.3 chromosomal region, containing miR-15 and miR-16, are frequent in Chronic Lymphocytic Leukemia (CLL).
• miRNAs function as both oncogenes and tumor suppressors in CLL, impacting disease onset and progression.

Purpose of the Study:

• To review the involvement of miRNAs in the pathogenesis and progression of Chronic Lymphocytic Leukemia (CLL).
• To explore the potential of miRNAs as biomarkers for CLL onset and advancement.
• To highlight the need for further research into miRNA mechanisms in CLL.

Main Methods:

• Literature review focusing on miRNA involvement in CLL.
• Analysis of chromosomal abnormalities associated with CLL, particularly 13q14.3 deletions.
• Synthesis of current knowledge on miRNA roles as oncogenes and tumor suppressors in leukemia.

Main Results:

• miRNAs are implicated in key cellular processes disrupted in CLL.
• Specific miRNA deletions (e.g., miR-15, miR-16) are linked to CLL development.
• miRNAs exhibit dual roles as oncogenes and tumor suppressors in CLL.

Conclusions:

• miRNAs are integral to CLL pathogenesis and disease progression.
• Further investigation into miRNA regulatory networks is essential for understanding CLL.
• miRNAs hold potential as diagnostic and prognostic markers for CLL.